Hospital Choice Key in Post-Myocardial Infarction Survival

Share this content:
Hospital Choice Key in Post-Myocardial Infarction Survival
Hospital Choice Key in Post-Myocardial Infarction Survival

FRIDAY, Oct. 7, 2016 (HealthDay News) -- Older patients with myocardial infarction (MI) who receive immediate high-quality care from their hospital often receive a long-term survival advantage, according to a study published in the Oct. 6 issue of the New England Journal of Medicine.

Emily Bucholz, M.D., Ph.D., M.P.H., a resident physician at Boston Children's Hospital, and colleagues reviewed 119,735 Medicare-covered MI patients treated at 1,824 hospitals across the United States between 1994 and 1996. The review included an average 17-year follow-up to track how long the patients lived. Hospitals were ranked as "high-performing" or "low-performing" based solely on the 30-day survival rates of the MI patients, who were an average of 76 years old.

The research team discovered that patients treated at high-performing hospitals had an overall increased life expectancy, compared to others treated at hospitals where more patients die during the first month of care. The average survival advantage was found to be between 0.74 and 1.14 years.

"One year is actually a fairly substantial amount of time for these patients," Bucholz told HealthDay. "From a policy level, investing in initiatives that improve short-term performance actually have long-term implications for patient outcomes."

Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »


Sign up for myCME e-newsletters


Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

SABCS: Artificial Intelligence May Aid Doctors in Breast Cancer Care

SABCS: Artificial Intelligence May Aid Doctors in Breast ...

'Watson Oncology' agreed with doctors 90 percent of the time in many cases, researchers find

SABCS: Scalp-Cooling System Can Reduce Chemo-Related Hair Loss

SABCS: Scalp-Cooling System Can Reduce Chemo-Related Hair Loss

Devices reduce blood flow to hair follicles during chemotherapy treatments

SABCS: Aromatase Inhibitors Tied to Reduced Endothelial Function

SABCS: Aromatase Inhibitors Tied to Reduced Endothelial Function

Women on aromatase inhibitors exhibit less elasticity in their blood vessels

is free, fast, and customized just for you!

Already a member?

Sign In Now »